Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
GNSC-001 by Genascence for Osteoarthritis: Likelihood of Approval
GNSC-001 is under clinical development by Genascence and currently in Phase I for Osteoarthritis. According to GlobalData, Phase I drugs...